Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank M Balis

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Pediatric Blood & Cancer|December 19, 2013
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621)Elizabeth Fox, Yael P Mosse', Holly M Meany, et al.
The New England Journal of Medicine|August 6, 2004
Loss of Smad3 in acute T-cell lymphoblastic leukemiaLawrence A Wolfraim, Tania M Fernandez, Mizuko Mamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumorsElizabeth Fox, John M Maris, Brigitte C Widemann, et al.
Journal of Neuro-Oncology|October 5, 2011
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium studyKatherine E Warren, Sri Gururangan, J Russell Geyer, et al.
Journal of the National Cancer Institute|October 21, 2004
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2Brigitte C Widemann, Frank M Balis, Aiman Shalabi, et al.
Pediatric Blood & Cancer|February 24, 2015
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology GroupElliot Stieglitz, Ashley F Ward, Robert B Gerbing, et al.
Cardio-Oncology (London, England)|May 17, 2025
Alternative mRNA splicing in anthracycline-induced cardiomyopathy - a COG-ALTE03N1 reportPurnima Singh, David K Crossman, Changde Cheng, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected childrenRohan Hazra, Frank M Balis, Antonella N Tullio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with VandetanibIra L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pediatric Blood & Cancer|April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|December 19, 2013
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621)Elizabeth Fox, Yael P Mosse', Holly M Meany, et al.
The New England Journal of Medicine|August 6, 2004
Loss of Smad3 in acute T-cell lymphoblastic leukemiaLawrence A Wolfraim, Tania M Fernandez, Mizuko Mamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumorsElizabeth Fox, John M Maris, Brigitte C Widemann, et al.
Journal of Neuro-Oncology|October 5, 2011
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium studyKatherine E Warren, Sri Gururangan, J Russell Geyer, et al.
Journal of the National Cancer Institute|October 21, 2004
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2Brigitte C Widemann, Frank M Balis, Aiman Shalabi, et al.
Pediatric Blood & Cancer|February 24, 2015
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology GroupElliot Stieglitz, Ashley F Ward, Robert B Gerbing, et al.
Cardio-Oncology (London, England)|May 17, 2025
Alternative mRNA splicing in anthracycline-induced cardiomyopathy - a COG-ALTE03N1 reportPurnima Singh, David K Crossman, Changde Cheng, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected childrenRohan Hazra, Frank M Balis, Antonella N Tullio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with VandetanibIra L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pediatric Blood & Cancer|April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Pageof 10